Scientific and operational leadership for a portfolio of projects to ensure high quality, innovative and effective support to clinical development projects in China. Provide project leadership for projects in region, and supervise direct reports responsible for project leadership Ensure high quality contribution to development strategies together with the local Chinese team and PK PTRs of the global IPTs Provide/Ensure high quality, timely, efficient, and high standard scientific inputs to trial protocols/data analysis/reports, and regulatory submissions in China Represent the pharmacokinetics discipline and ensure high quality interactions with the Chinese health authority, external investigators, and various internal Novartis TAs Establish and maintain sound working relationships with partners and customers Initiate and support continuous improvement initiatives in global pharmacokinetics and partner functions Recruit, coach and develop talents in pharmacokinetics discipline in China Serve as a member on the global PK leadership team Provide input into the PK budget, and manage resources in China PK group Minimum requirements Minimum of a Ph.D. in Pharmacology, Pharmaceutics, or related disciplines (or equivalent degree/knowledge/expertise). Seven to ten years of experience in pharmacokinetics or biopharmaceutics. Experience in international regulatory affairs including Chinese regulatory affairs, global drug development, project management required. Excellent verbal and written English and Chinese communication skills. Administrative management and team leadership experience desired.

企业介绍:
诺华（Novartis AG）是全球医药保健行业的领导者。其核心业务涉及专利药，非专利药，眼睛护理，消费者保健和动物保健等领域。诺华公司总部设在瑞士巴塞尔，业务遍及全球140多个国家和地区。 诺华（中国）生物医学研究有限公司是诺华全球研发组织――诺华生物医学研究所（NIBR）的第八个研究基地。我们位于中国上海市张江高科技园区，将成为诺华在亚洲的主要研究中心，以及除在欧美的研究中心外的最主要的研究中心。我们的研究和探索开发活动的重点是发现并开发创新疗法，用于治疗在亚洲远未达到医药需求的疾病。我们与从不同之处在于将专注现代药物的发现和开发方法的研究。最初阶段，研发工作将专注在引起中国地方性癌症的感染原因。我们还将开展临床试验，进行安全性研究，生物标志物和检测分析，表达谱、生物分析以及转化医学的研究。